Laboratory Corporation of America Holdings

NYSE:LHUnited States

Court with respect to motions filed in the chapter 11 cases; (x) objections to Invitae's recapitalization process or other pleadings filed with the Bankruptcy Court that could protract the chapter 11 cases; (xi) employee attrition and Invitae's ability to retain senior management and other key personnel due to the distractions and uncertainties caused by the chapter 11 cases; (xii) Invitae's ability to improve its liquidity and long-term capital structure and to address its debt service obligations through the restructuring; (xiii) Invitae's ability to comply with the restrictions imposed by the terms and conditions of the potential financing arrangements; (xiv) Invitae's ability to effectively implement its strategic initiatives; (xv) Invitae's liquidity needs to operate its business and execute its strategy, and related use of cash; (xvi) Invitae's ability to maintain relationships with suppliers, customers, employees, regulatory authorities and other third parties as a result of the chapter 11 cases; (xvii) the effects of the restructuring and the chapter 11 cases on Invitae and on the interests of various constituents, including holders of Invitae's common stock; (xviii) the Bankruptcy Court's rulings in the chapter 11 cases, including approvals related to the terms and conditions of any plan under chapter 11 and the outcome of the chapter 11 cases, generally; (xix) the length of time that Invitae will operate under chapter 11 protection and the continued availability of operating capital during the pendency of the chapter 11 cases; (xx) risks associated with third-party motions in the chapter 11 cases, which may interfere with Invitae's ability to consummate a plan under chapter 11 and the sale of assets to Labcorp; (xxi) increased administrative and legal costs related to the chapter 11 process; (xxii) other litigation and inherent risks involved in a bankruptcy process; (xxiii) Invitae's public securities' potential liquidity and trading; (xxiv) any impact resulting from the delisting of Invitae's common stock from the New York Stock Exchange and trading instead on the OTC Pink Marketplace; (xxv) and the other risks and uncertainties disclosed in Invitae's annual and quarterly periodic reports and other documents filed with the SEC. Additionally, there can be no assurances that the sale of the business will receive regulatory approval or that any sale will be successfully consummated. Forward-looking statements speak only as of the date they are made. Invitae undertakes no duty or obligation to update or revise these forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by law.